Culture & Tech
FDA Approves Pancreatic Cancer Drug That Nearly Doubled Survival In Trial
The U.S. Food and Drug Administration (FDA) on Wednesday approved a groundbreaking new treatment for advanced pancreatic cancer that nearly doubled median survival in a clinical trial, marking what experts are calling one of the biggest advances against the deadly disease in decades.
Read more at DAILY WIRE ›
Read the full story at
DAILY WIRE
The Gadsden Report aggregates and summarises headlines. The reporting above belongs to DAILY WIRE, and the link opens their page. This page exists so readers can find, share, and discuss the story here.